Loading...
IRadimed Q1 2025 Earnings Report
IRADIMED CORPORATION reported a strong first quarter in 2025, with record revenue and increased diluted EPS, while also declaring a regular quarterly cash dividend.
Key Takeaways
IRADIMED CORPORATION achieved record revenue of $19.5 million in the first quarter of 2025, an 11% increase year-over-year, alongside a 16% increase in GAAP diluted EPS to $0.37 and a 17% increase in non-GAAP diluted EPS to $0.42. The company also declared a quarterly cash dividend of $0.17 per common share.
Record revenue of $19.5 million was reported for Q1 2025, marking an 11% increase from the same period in 2024.
GAAP diluted EPS increased by 16% to $0.37, and non-GAAP diluted EPS increased by 17% to $0.42 for Q1 2025.
A regular quarterly cash dividend of $0.17 per common share was declared, payable on May 30, 2025.
The gross profit margin remained constant at 76.1% for both Q1 2025 and Q1 2024.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
For the second quarter of 2025, IRADIMED expects revenue between $19.7 million and $19.9 million, GAAP diluted EPS between $0.37 and $0.40, and non-GAAP diluted EPS between $0.41 and $0.44. For the full year 2025, the company anticipates revenue of $78.0 million to $82.0 million, GAAP diluted EPS of $1.55 to $1.65, and non-GAAP diluted EPS of $1.71 to $1.81.
Positive Outlook
- Anticipated continued revenue growth for Q2 2025 and full year 2025.
- Expected increase in GAAP diluted EPS for Q2 2025 and full year 2025.
- Expected increase in non-GAAP diluted EPS for Q2 2025 and full year 2025.
- New manufacturing facility on track for completion in July 2025, supporting planned growth.
- Reaffirmation of full year 2025 revenue and earnings guidance.
Challenges Ahead
- Potential disruptions in the limited supply chain for products.
- Risks related to receiving FDA 510(k) clearance for new products.
- Unexpected costs, delays, or diversion of management's attention associated with new product development.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...